Details for New Drug Application (NDA): 216278
✉ Email this page to a colleague
NDA 216278 describes TIOPRONIN, which is a drug marketed by Amneal, Par Pharm, Torrent, Par Pharm Inc, and Teva Pharms Usa Inc, and is included in five NDAs. It is available from three suppliers. Additional details are available on the TIOPRONIN profile page.
The generic ingredient in TIOPRONIN is tiopronin. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tiopronin profile page.
The generic ingredient in TIOPRONIN is tiopronin. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tiopronin profile page.
Pharmacology for NDA: 216278
| Mechanism of Action | Cystine Disulfide Reduction |
Suppliers and Packaging for NDA: 216278
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TIOPRONIN | tiopronin | TABLET, DELAYED RELEASE;ORAL | 216278 | ANDA | Amneal Pharmaceuticals NY LLC | 60219-2009 | 60219-2009-9 | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (60219-2009-9) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 300MG | ||||
| Approval Date: | Aug 15, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
